Company Profile (AI Text)
Name: OsNovum
Canonical URL: https://wefunder.com/osnovum
Updated at: 2026-06-04T05:02:21Z

Tagline: Revolutionizing the $25B osteoporosis industry with a novel regenerative solution for weak bones
Elevator pitch: OsNovum has developed the technology to regenerate bone to maintain skeletal health. Weak bones are a major reason for frailty as we age. OsNovum has the proven technology to regenerate bone but will also open clinics devoted exclusively to skeletal heath and the prevention of frailty as we age.

Key claims:
- Total raised on Wefunder: 383626 | citation: https://wefunder.com/osnovum#claim-total-raised
- Total investors: 230 | citation: https://wefunder.com/osnovum#claim-total-investors

Verified facts:
- Total raised on Wefunder: 383626 | observed_at: 2026-06-04T05:02:21Z | expires_at: 2026-06-05T05:02:21Z
- Total investors: 230 | observed_at: 2026-06-04T05:02:21Z | expires_at: 2026-06-05T05:02:21Z

Computed metrics:
- total_amount_raised: 383626
- total_investors: 230
- team_size: 3
- featured_investor_count: 1
- faq_count: 5
- recent_post_count: 10

Quick facts:
- Patented bone-regenerating technology ready to disrupt the $25B osteoporosis market. | citation: https://wefunder.com/osnovum#claim-fact-1
- FDA-cleared for maxillofacial bone; streamlined path to clearance for full skeletal applications. | citation: https://wefunder.com/osnovum#claim-fact-2
- Thousands of successful patients treated with regenerative bone solutions using proven materials. | citation: https://wefunder.com/osnovum#claim-fact-3
- Clear exit strategy within 3 years, with potential acquisition by industry leaders. | citation: https://wefunder.com/osnovum#claim-fact-4
- Novel alternative to osteoporosis drugs with no systemic side effects—patients demand better. | citation: https://wefunder.com/osnovum#claim-fact-5
- Innovative specialty clinics will deliver localized treatment with scalable patient care models. | citation: https://wefunder.com/osnovum#claim-fact-6

FAQ:
- Q: Hi. I'm very interested but I have some questions if you don't mind: -How much will each application cost? -Will it be covered by insurance? -What are your revenue goals for the next 5 years? This is key for me as it will give me an idea of the company's potential and what kin...
  A: Hello Leonardo All good questions. The cost will of course vary with the location and size of the lesion but we expect the charge approximately $5,000 per hip. Individual vertebrae would be less if multiple vertebrae are treated at once. OsNovum is classified as a bone graft and it will be covered as a bone graft. Virtually any insurance company would be happy to pay $5,000 to prevent a hip fracture. The plane is taxiing so I will complete my response latter. 
- Q: Cpñica okay, vacations from back surgery what can I be rewarded from medical malpractice
  A: Cpnica? The vast majority of back surgeries are performed as a result of disk pathology. OsNovum has nothing to do with disk or cartilage pathology.
- Q: I hope you can finish your answer before the early bird terms end, I need the revenue goals to make my decision.
  A: Hello Leonardo Please read the following and get back to me. I just recently posted this to our investors. All the best,Financial Projections To: OsNovum Investors Here at OsNovum/SteinerBio we need to deal with facts. When treating a patient, you must put aside any bias or dogma and honestly critique how your patient responds to therapy. You cannot let what you want to happen cloud the reality of what is actually happening. This is ingrained in us and as a result we cannot look at business a...
- Q: Thanks for that. I was just hoping for your personal revenue goals, what numbers you are aiming to reach year by year. What's the margin on a $5,000 application? Can You disclose that?
  A: Revenue goals We are wrapping up the FDA submission at this time and will hopefully submit in about 3 months. We could get approval in 6 months to a year and then we go to market. The costs associated with osteoporotic fractures is immense and that is related to our income. Let’s limit our discussion to about vertebral osteoporotic fractures to get a sense of the market and revenue stream. There are approximately 700,000 vertebral compression fractures per year in the US. There are currently ...
- Q: Hello Dr. Steiner Iam interested in investing and would like to know what distinguishes OsNovum from other treatments in the market such as Teriparatide(Forteo), Abaloparatide (Tymlos), Romosozumab (Evenity). In other words, what is your competitive advantage? Thanks
  A: Hello SalehThe medications you list are systemic medications. They require continued use and have significant side effects. OsNovum in applied locally to the affected bone via a syringe. It is a one time application to regenerate the health of the bone. Our experience in the jaw indicates the effect is long lasting as we have not seen a decline is density over time. How long the effect will be in the rest of the skeleton is unknown at this time. OsNovum has no known side effects. All the best...

Recent posts:
- OsNovum Status (2021-06-02T16:25:29Z) https://wefunder.com/feed/145483
- New Methods of Diagnosing Who Will Suffer a Bone Fracture (2021-01-30T21:25:46Z) https://wefunder.com/feed/141412
- Research findings: OsNovum reduces inflammation and stimulates bone growth. (2021-01-25T21:24:02Z) https://wefunder.com/feed/141390
- Bone Repair vs Bone Regeneration (2021-01-23T20:48:10Z) https://wefunder.com/feed/141360
- Factors Affecting Osteoporosis (2021-01-19T21:28:01Z) https://wefunder.com/feed/141221
- OsNovum nearing 150K in funding. (2021-01-16T21:03:11Z) https://wefunder.com/feed/141121
- Osteoporosis drugs- effectiveness and side effects (2021-01-01T23:03:17Z) https://wefunder.com/feed/140658
- OsNovum testing progress (2020-12-24T20:20:49Z) https://wefunder.com/feed/140153
- OsNovum Owners update: FDA testingThe FDA does not have rules to follow when submitting a material for clearance to market a product. The FDA only has guidelines and it is up to the company to convince the FDA that the tests performed on the product are sufficient to determine that product is safe and effective. In addition to no rules, what is accepted will be determined by the attitude of the office who reviews the submission. When you submit to the FDA the officer will reply with a list of... (2020-12-15T00:10:30Z) https://wefunder.com/feed/139905
- I have just responded to an inquiry about projected revenue for OsNovum. I used percutaneous vertebroplasty as an example of how common collapsed vertebra are and the cost associated with treatment. I used these figures to give an idea of how OsNovum can be used for this problem and how much revenue can be generated. Percutaneous vertebroplasty injects plastic into the vertebrae to support it and stabilize it. The plastic never goes away. The type of material used in percutaneous vertebroplas... (2020-12-08T22:38:22Z) https://wefunder.com/feed/139697